These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24619139)

  • 1. Discrimination of prostate carcinoma from benign prostate tissue fragments in vitro by estimating the gross biochemical alterations through Raman spectroscopy.
    Silveira L; Leite KR; Silveira FL; Srougi M; Pacheco MT; Zângaro RA; Pasqualucci CA
    Lasers Med Sci; 2014 Jul; 29(4):1469-77. PubMed ID: 24619139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating model for diagnosis of basal cell carcinoma and melanoma in vitro based on the Raman spectra of selected biochemicals.
    Silveira L; Silveira FL; Bodanese B; Zângaro RA; Pacheco MT
    J Biomed Opt; 2012 Jul; 17(7):077003. PubMed ID: 22894516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Raman spectroscopy to evaluate the biochemical composition of normal and tumoral human brain tissues for diagnosis.
    Aguiar RP; Falcão ET; Pasqualucci CA; Silveira L
    Lasers Med Sci; 2022 Feb; 37(1):121-133. PubMed ID: 33159308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprocessing Tools Applied to Improve the Assessment of Aldrin Effects on Prostate Cancer Cells Using Raman Spectroscopy.
    Olmos V; Bedia C; Tauler R; Juan A
    Appl Spectrosc; 2018 Mar; 72(3):489-500. PubMed ID: 29154675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
    Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
    J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of basal cell carcinoma and melanoma from normal skin biopsies in vitro through Raman spectroscopy and principal component analysis.
    Bodanese B; Silveira FL; Zângaro RA; Pacheco MT; Pasqualucci CA; Silveira L
    Photomed Laser Surg; 2012 Jul; 30(7):381-7. PubMed ID: 22693951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of non-melanoma skin lesions from non-tumor human skin tissues in vivo using Raman spectroscopy and multivariate statistics.
    Silveira FL; Pacheco MT; Bodanese B; Pasqualucci CA; Zângaro RA; Silveira L
    Lasers Surg Med; 2015 Jan; 47(1):6-16. PubMed ID: 25583686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating normal and basal cell carcinoma human skin tissues in vitro using dispersive Raman spectroscopy: a comparison between principal components analysis and simplified biochemical models.
    Bodanese B; Silveira L; Albertini R; Zângaro RA; Pacheco MT
    Photomed Laser Surg; 2010 Aug; 28 Suppl 1():S119-27. PubMed ID: 20649423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Raman spectroscopy to provide an estimation of the gross biochemistry associated with urological pathologies.
    Stone N; Hart Prieto MC; Crow P; Uff J; Ritchie AW
    Anal Bioanal Chem; 2007 Mar; 387(5):1657-68. PubMed ID: 17123068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study.
    Shao X; Pan J; Wang Y; Zhu Y; Xu F; Shangguan X; Dong B; Sha J; Chen N; Chen Z; Wang T; Liu S; Xue W
    Nanomedicine; 2017 Apr; 13(3):1051-1059. PubMed ID: 27979746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-modality probe intended for prostate cancer detection combining Raman spectroscopy and tactile resonance technology--discrimination of normal human prostate tissues ex vivo.
    Nyberg M; Jalkanen V; Ramser K; Ljungberg B; Bergh A; Lindahl OA
    J Med Eng Technol; 2015 Apr; 39(3):198-207. PubMed ID: 25762203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal-subtracted preprocessing of Raman spectra aiming to discriminate skin actinic keratosis and neoplasias from benign lesions and normal skin tissues.
    Silveira L; Pasqualucci CA; Bodanese B; Pacheco MTT; Zângaro RA
    Lasers Med Sci; 2020 Jul; 35(5):1141-1151. PubMed ID: 31853808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics.
    Aubertin K; Trinh VQ; Jermyn M; Baksic P; Grosset AA; Desroches J; St-Arnaud K; Birlea M; Vladoiu MC; Latour M; Albadine R; Saad F; Leblond F; Trudel D
    BJU Int; 2018 Aug; 122(2):326-336. PubMed ID: 29542855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of zone-specific spectral signatures in normal human prostate using Raman spectroscopy.
    Patel II; Martin FL
    Analyst; 2010 Dec; 135(12):3060-9. PubMed ID: 20949203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
    Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
    Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of picosecond Kerr-gated Raman spectroscopy to suppress signals from both surface and deep layers in bladder and prostate tissue.
    Prieto MC; Matousek P; Towrie M; Parker AW; Wright M; Ritchie AW; Stone N
    J Biomed Opt; 2005; 10(4):44006. PubMed ID: 16178640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of fiberoptic near-infrared raman spectroscopy for diagnosis of bladder and prostate cancer.
    Crow P; Molckovsky A; Stone N; Uff J; Wilson B; WongKeeSong LM
    Urology; 2005 Jun; 65(6):1126-30. PubMed ID: 15913721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
    Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
    Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostate cancer by Raman spectroscopy: A multivariate study on patients with normal and altered PSA values.
    Correia NA; Batista LTA; Nascimento RJM; Cangussú MCT; Crugeira PJL; Soares LGP; Silveira L; Pinheiro ALB
    J Photochem Photobiol B; 2020 Mar; 204():111801. PubMed ID: 31978674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.